Search Results
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Min Ren in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Qianlan Yao in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Longlong Bao in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Zhiting Wang in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Ran Wei in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Qianming Bai in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Bo Ping in
Google Scholar
PubMed
Department of Ultrasound, Fudan University Shanghai Cancer Center, Shanghai, China
Search for other papers by Cai Chang in
Google Scholar
PubMed
Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
Search for other papers by Yu Wang in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Xiaoyan Zhou in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Xiaoli Zhu in
Google Scholar
PubMed
overall accuracy reached 98.0%. It's worth noting that four Bethesda I/II nodules diagnosed as malignant papillary thyroid microcarcinomas were all NGS positive in FNA samples. Furthermore, compared to the combination of cytology and a single BRAF
Search for other papers by Francesca Carlomagno in
Google Scholar
PubMed
of the RET gene have been identified in two different types of thyroid neoplasia: medullary thyroid carcinoma (MTC) and papillary thyroid carcinoma. RET Mutations in MTC: A New Target for Cancer Treatment MTC arises from neural crest
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France
Search for other papers by Constance Xhaard in
Google Scholar
PubMed
Search for other papers by Juan J. Lence-Anta in
Google Scholar
PubMed
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France
Search for other papers by Yan Ren in
Google Scholar
PubMed
Rhône-Alpes Thyroid Cancer Registry, Cancer Research Center of Lyon (UMR INSERM 1052, CNRS 5286), RTH Laennec Faculty of Medicine, University of Lyon, Lyon
Search for other papers by Françoise Borson-Chazot in
Google Scholar
PubMed
Search for other papers by Geneviève Sassolas in
Google Scholar
PubMed
Search for other papers by Claire Schvartz in
Google Scholar
PubMed
Search for other papers by Marc Colonna in
Google Scholar
PubMed
French National Registry of Childhood Solid Tumours, CHU, Nancy
Search for other papers by Brigitte Lacour in
Google Scholar
PubMed
Search for other papers by Arlette Danzon in
Google Scholar
PubMed
Search for other papers by Michel Velten in
Google Scholar
PubMed
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France
Search for other papers by Enora Clero in
Google Scholar
PubMed
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France
Search for other papers by Stéphane Maillard in
Google Scholar
PubMed
Search for other papers by Emilie Marrer in
Google Scholar
PubMed
Search for other papers by Laurent Bailly in
Google Scholar
PubMed
Search for other papers by Eugènia Mariné Barjoan in
Google Scholar
PubMed
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Search for other papers by Jacques Orgiazzi in
Google Scholar
PubMed
Université Paris-Saclay, Villejuif, France
Search for other papers by Elisabeth Adjadj in
Google Scholar
PubMed
Search for other papers by Celia M. Pereda in
Google Scholar
PubMed
Search for other papers by Silvia Turcios in
Google Scholar
PubMed
Search for other papers by Milagros Velasco in
Google Scholar
PubMed
Search for other papers by Mae Chappe in
Google Scholar
PubMed
Search for other papers by Idalmis Infante in
Google Scholar
PubMed
Search for other papers by Marlene Bustillo in
Google Scholar
PubMed
Search for other papers by Anabel García in
Google Scholar
PubMed
Search for other papers by Sirced Salazar in
Google Scholar
PubMed
Search for other papers by Regla Rodriguez in
Google Scholar
PubMed
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France
Search for other papers by Mohamed Amine Benadjaoud in
Google Scholar
PubMed
Search for other papers by Rosa M. Ortiz in
Google Scholar
PubMed
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France
Search for other papers by Carole Rubino in
Google Scholar
PubMed
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France
Search for other papers by Florent de Vathaire in
Google Scholar
PubMed
, Wicklund KG, Daling JR: Reproductive factors and risk of papillary thyroid cancer in women. Am J Epidemiol 2000;151:765-772. 10.1093/oxfordjournals.aje.a010276 10965973 6 Negri E, Dal Maso L, Ron E, La Vecchia C, Mark SD, Preston-Martin S, McTiernan
Search for other papers by Maria Mavromati in
Google Scholar
PubMed
Search for other papers by Essia Saiji in
Google Scholar
PubMed
Search for other papers by Marco Stefano Demarchi in
Google Scholar
PubMed
Search for other papers by Vincent Lenoir in
Google Scholar
PubMed
Search for other papers by Amanda Seipel in
Google Scholar
PubMed
Search for other papers by Paulina Kuczma in
Google Scholar
PubMed
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
Search for other papers by Minerva Becker in
Google Scholar
PubMed
Search for other papers by Eugenio Fernandez in
Google Scholar
PubMed
Search for other papers by Claudio De Vito in
Google Scholar
PubMed
Search for other papers by Frédéric Triponez in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Journal of Clinical Investigation 2009 39 699 – 706 . ( https://doi.org/10.1111/j.1365-2362.2009.02162.x ) 3 Leboulleux S Tuttle RM Pacini F & Schlumberger M . Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance
Center for Genomic Research, Italy
Search for other papers by Marco Marino in
Google Scholar
PubMed
Azienda USL of Modena, Modena, Italy
Search for other papers by Maria Laura Monzani in
Google Scholar
PubMed
Azienda USL of Modena, Modena, Italy
Search for other papers by Giulia Brigante in
Google Scholar
PubMed
Azienda USL of Modena, Modena, Italy
Search for other papers by Katia Cioni in
Google Scholar
PubMed
Azienda USL of Modena, Modena, Italy
Search for other papers by Bruno Madeo in
Google Scholar
PubMed
Azienda USL of Modena, Modena, Italy
Search for other papers by Daniele Santi in
Google Scholar
PubMed
Search for other papers by Antonino Maiorana in
Google Scholar
PubMed
Search for other papers by Stefania Bettelli in
Google Scholar
PubMed
Center for Genomic Research, Italy
Search for other papers by Valeria Moriondo in
Google Scholar
PubMed
Center for Genomic Research, Italy
Search for other papers by Elisa Pignatti in
Google Scholar
PubMed
Azienda USL of Modena, Modena, Italy
Search for other papers by Lara Bonacini in
Google Scholar
PubMed
Search for other papers by Cesare Carani in
Google Scholar
PubMed
Azienda USL of Modena, Modena, Italy
Search for other papers by Vincenzo Rochira in
Google Scholar
PubMed
Center for Genomic Research, Italy
Azienda USL of Modena, Modena, Italy
Search for other papers by Manuela Simoni in
Google Scholar
PubMed
Introduction BRAF point mutations are common in papillary thyroid cancer (PTC) [ 1 ]. The most frequent missense mutation BRAF V600E is due to the replacement of valine by glutamic acid (NM_004333.4), resulting in a constitutive MEK
Search for other papers by Catherine Brophy in
Google Scholar
PubMed
Search for other papers by Rania Mehanna in
Google Scholar
PubMed
Search for other papers by Julie McCarthy in
Google Scholar
PubMed
Search for other papers by Antoinette Tuthill in
Google Scholar
PubMed
Search for other papers by Matthew S. Murphy in
Google Scholar
PubMed
Search for other papers by Patrick Sheahan in
Google Scholar
PubMed
A: An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003;13:381-387. 10.1089/105072503321669875 12804106
Medical School, University of Milan, Milan, Italy
Search for other papers by Stamatina Ioakim in
Google Scholar
PubMed
Division of Diabetes, Endocrinology & Gastroenterology, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
Search for other papers by Akheel A Syed in
Google Scholar
PubMed
Search for other papers by George Zavros in
Google Scholar
PubMed
Search for other papers by Michalis Picolos in
Google Scholar
PubMed
Department of Endocrinology and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Department of Diabetes, Endocrinology & Obesity Medicine, Salford Royal NHS Foundation & University Teaching Trust, Salford, UK
Medical School, European University of Cyprus, Nicosia, Cyprus
Search for other papers by Angelos Kyriacou in
Google Scholar
PubMed
papillary microcarcinoma while the remainder were classic papillary thyroid carcinomas (PTC). An additional three cases (in two patients) of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) were identified; nevertheless
Search for other papers by Cosimo Durante in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Search for other papers by Agnieszka Czarniecka in
Google Scholar
PubMed
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
Search for other papers by Gilles Russ in
Google Scholar
PubMed
Search for other papers by Fernando Schmitt in
Google Scholar
PubMed
Search for other papers by Paula Soares in
Google Scholar
PubMed
Search for other papers by Tamas Solymosi in
Google Scholar
PubMed
Search for other papers by Enrico Papini in
Google Scholar
PubMed
in unselected thyroid nodule populations generally ranges from 1 to 5%, with variation related to selection criteria and the population under evaluation, for example, whether papillary micro-carcinomas are included or not ( 2 ). Thus, most lesions are
Search for other papers by Aamna Hassan in
Google Scholar
PubMed
Search for other papers by Saima Riaz in
Google Scholar
PubMed
Search for other papers by Humayun Bashir in
Google Scholar
PubMed
Search for other papers by M. Khalid Nawaz in
Google Scholar
PubMed
Search for other papers by Raza Hussain in
Google Scholar
PubMed
M, Nawaz MK, Syed AA, Bashir H: Survival analysis of papillary thyroid carcinoma in relation to stage and recurrence risk: a 20-year experience in Pakistan. Clin Nucl Med 2016;41:606-613. 10.1097/RLU.0000000000001237 27124680 6 Grabellus F
Search for other papers by Hirosuke Danno in
Google Scholar
PubMed
Search for other papers by Eijun Nishihara in
Google Scholar
PubMed
Search for other papers by Kazuyoshi Kousaka in
Google Scholar
PubMed
Search for other papers by Tomohiko Nakamura in
Google Scholar
PubMed
Search for other papers by Toshihiko Kasahara in
Google Scholar
PubMed
Search for other papers by Takumi Kudo in
Google Scholar
PubMed
Search for other papers by Mitsuru Ito in
Google Scholar
PubMed
Search for other papers by Shuji Fukata in
Google Scholar
PubMed
Search for other papers by Mitsushige Nishikawa in
Google Scholar
PubMed
Search for other papers by Akira Miyauchi in
Google Scholar
PubMed
-Lenhart syndrome and a papillary thyroid microcarcinoma . BMC Endocr Disord . 2013 May 8 ; 13 : 16 . http://dx.doi.org/10.1186/1472-6823-13-16 16 Stanzel S , Gyürüs P , Kresnik E , Aigner R . A rare case of marine-Lenhart syndrome with